-5%
Cabita (Capecitabine) 500 mg and 150 mg Tablets are a nucleoside metabolic inhibitor with antineoplastic properties, primarily used in the treatment of certain cancers.Â
- Adjuvant Colon Cancer: For patients with Dukes’ C colon cancer.
- Metastatic Colorectal Cancer: Used as first-line therapy when fluoropyrimidine alone is preferred.
- Metastatic Breast Cancer: In combination with docetaxel after failure of prior anthracycline-based therapy.
- As monotherapy for patients resistant to both paclitaxel and an anthracycline regimen.
Cabita 500mg Tablet contains capecitabine, an antineoplastic agent used to treat certain types of cancer, including those affecting the colon, rectum, stomach, and breasts. It can be prescribed on its own or alongside other medications.
This medication is not suitable for individuals with severe liver or kidney conditions. It should be used with caution in those with liver or kidney problems, heart disease, neurological disorders, diabetes, or a history of eye issues. Always consult your doctor before use.
Cabita 500 Tablet is not recommended for pregnant or breastfeeding women, as well as for children or adolescents. Consultation with a healthcare professional is advised before starting this medication.
